Antipsychotic News and Research

RSS

Antipsychotics are medicines used to treat the symptoms of mental disorders such as schizophrenia, depression, bipolar disorder (sometimes called manic-depressive illness), anxiety disorders, and attention deficit-hyperactivity disorder (ADHD). Sometimes medications are used with other treatments such as psychotherapy.

Promising treatment for schizophrenia found in the form of avatars

Computer simulations of the faces behind the voices heard by sufferers of schizophrenia may give patients the power to cope better with these distressing hallucinations.

24 Nov 2017

Reducing use of antibiotics not sufficient to reverse drug resistance

Researchers have discovered that reducing the use of antibiotics will not be enough to reverse the growing prevalence of antibiotic resistance for some types of bacteria.

22 Nov 2017

Heart rate variability measured by electrocardiogram can help differentiate bipolar from major depression

A groundbreaking Loyola Medicine study suggests that a simple 15-minute electrocardiogram could help a physician determine whether a patient has major depression or bipolar disorder.

21 Nov 2017

Digital pills can help track opioid use patterns

Digital pills - gelatin capsules that contain an ingestible sensor along with medication - can help track patterns of drug use, and Brigham and Women's Hospital clinicians are among the first to explore the application of this new technology among patients being prescribed opioids.

20 Nov 2017

FDA approves first drug with digital ingestion tracking system

The U.S. Food and Drug Administration today approved the first drug in the U.S. with a digital ingestion tracking system. Abilify MyCite (aripiprazole tablets with sensor) has an ingestible sensor embedded in the pill that records that the medication was taken.

14 Nov 2017

ACADIA Pharmaceuticals announces results from Phase II study of antipsychotic in Alzheimer's disease psychosis

ACADIA Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system (CNS) disorders, today announced the presentation of data from the Phase II -019 Study of pimavanserin in Alzheimer's disease psychosis at the 10th Clinical Trials on Alzheimer's Disease meeting in Boston.

3 Nov 2017

Sunovion announces results from Phase 3 clinical study of new drug in children, adolescents with bipolar depression

Sunovion Pharmaceuticals Inc. today announced post-hoc analysis results of a positive Phase 3 placebo-controlled clinical study, as well as interim data from a long-term open-label extension study evaluating Latuda (lurasidone HCI) in children and adolescents (10 to 17 years of age) with major depressive episodes associated with bipolar I disorder (bipolar depression).

28 Oct 2017

Study shows efficacy of antipsychotic as adjunctive therapy for gastroparesis in emergency department

Haloperidol is an effective first-line agent in combination with standard analgesic and antiemetic agents for the treatment of gastroparesis in the emergency department.

26 Oct 2017

USC study reveals how schizophrenia has biological effect on the entire brain

Some 40 years since CT scans first revealed abnormalities in the brains of schizophrenia patients, international scientists say the disorder is a systemic disruption to the brain's entire communication system.

17 Oct 2017

Special issue of Current Diabetes Review explores the management of diabetes in medically complex patients

Diabetes affects roughly 30 million Americans, and is one of the leading causes of disability and mortality. As a result, organizations such as the American Diabetes Association (ADA), Endocrine Society and American Association of Clinical Endocrinologists (AACE) have made efforts to move away from the one size fits all management of diabetes.

30 Sep 2017

Researchers to study how music program can positively affect lives of people with dementia

With a new grant from the National Institute on Aging, Brown University researchers plan to conduct a randomized trial of whether a nursing home program that involves listening to a personalized music playlist can improve care and outcomes among residents with dementia.

20 Sep 2017

New approaches to prevent or treat antipsychotic-induced supersensitivity psychosis

In the current issue of Psychotherapy and Psychosomatic, professor Guy Chouinard, one of the most important psychopharmacologists, provides a synthesis of the data that are concerned with neglected side effects of commonly used psychotropic drugs.

8 Sep 2017

Study: Low long-term use of psychiatric drugs does not appear to affect cognition in schizophrenia

A long-term study has found that low cumulative exposure to benzodiazepine and antidepressant medications does not seem to affect cognition in schizophrenia.

5 Sep 2017

First-of-its-kind study compares long-term weight gain across different psychotic disorders

Obesity is a major public health problem in the United States, as an estimated 35 percent of Americans are obese and have a body mass index (BMI) of 30 or more.

23 Aug 2017

Antipsychotics commonly prescribed to adults with IDD, study finds

Antipsychotic medication is frequently being prescribed to individuals with intellectual and developmental disabilities (IDD), often without a psychiatric diagnosis, a new study conducted by the Centre for Addiction and Mental Health and Institute for Clinical Evaluative Sciences has found.

23 Aug 2017

UC Irvine pharmacology researchers unearth potential roots of schizophrenia

An abundance of an amino acid called methionine, which is common in meat, cheese and beans, may provide new clues to the fetal brain development that can manifest in schizophrenia, University of California, Irvine pharmacology researchers report in the journal Molecular Psychiatry.

16 Aug 2017

Antipsychotic News and Research

Promising treatment for schizophrenia found in the form of avatars

Reducing use of antibiotics not sufficient to reverse drug resistance

Heart rate variability measured by electrocardiogram can help differentiate bipolar from major depression

Digital pills can help track opioid use patterns

FDA approves first drug with digital ingestion tracking system

ACADIA Pharmaceuticals announces results from Phase II study of antipsychotic in Alzheimer's disease psychosis

Sunovion announces results from Phase 3 clinical study of new drug in children, adolescents with bipolar depression

Study shows efficacy of antipsychotic as adjunctive therapy for gastroparesis in emergency department

USC study reveals how schizophrenia has biological effect on the entire brain

Special issue of Current Diabetes Review explores the management of diabetes in medically complex patients

Researchers to study how music program can positively affect lives of people with dementia

New approaches to prevent or treat antipsychotic-induced supersensitivity psychosis

Study: Low long-term use of psychiatric drugs does not appear to affect cognition in schizophrenia

First-of-its-kind study compares long-term weight gain across different psychotic disorders

Antipsychotics commonly prescribed to adults with IDD, study finds

UC Irvine pharmacology researchers unearth potential roots of schizophrenia

Experts explore ways to improve safety of care for nursing home residents with dementia

Climbing cost of decades-old drugs threatens to break Medicaid bank

Researchers explore use of potentially inappropriate medications among frail nursing home residents

Researchers identify decreased brain pH levels in mouse models of mental disorders

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News